Product News and Articles

11 - 20 of 42 Articles Previous 2 3 4 Next Next


Liquichek™ Maternal Serum II Control

Bio-Rad Announces the Release of Liquichek™ Maternal Serum II Control. The Multi-Constituent Control Offers Increased Efficiency and Confidence in Test Results.
More »


Bio-Rad Announces CE IVD Marking of its QX200 Droplet Digital PCR System for Use as an In Vitro Diagnostic

Researchers can use the QX200 system for highly-accurate detection and quantification of nucleic acids, aiding clinical decision-making in the treatment of diseases ranging from cancer to transplant rejection and viral infection.
More »


Bio-Rad Unveils Critical Raw Material Antigens for Diagnostic Uses

Bio-Rad announced the launch of human recombinant protein antigens, which expand the company’s critical raw material offering.
More »


Bio-Rad Mission: Control™ Risk Management Software Launched at AACC in Atlanta

Bio-Rad Laboratories announced the launch of Bio-Rad Mission: Control™, the first objective risk management software to help laboratories identify the best QC rules and the right QC frequency to develop a customized quality control plan to deliver reliable test results.
More »


New Lyphochek® Allergen sIgE Controls

Bio-Rad Releases New Lyphochek® Allergen sIgE Controls to Monitor Precision of In Vitro Allergy Test Procedures. Offering Cost Savings, Increased Efficiencies, and Less Waste
More »


Important Information for Bio-Rad Customers in North America: Business Systems Update

Bio-Rad Laboratories will complete a business systems update on July 6. Impacts to business operations will be minimal, but North American customers should note that Bio-Rad will not ship products from July 1–July 5; shipping will resume on July 6. New customer account numbers and other changes to customer-facing data formats will also be implemented on this date.
More »


Geenius HIV-1/HIV-2 Supplemental Assay Press Release

Bio-Rad Laboratories' Geenius HIV-1/HIV-2 Supplemental Assay can differentiate circulating antibodies to Human Immunodeficiency Virus Types 1 and 2 in whole blood, serum and plasma. Earlier this month, the company announced that it received Premarket Application Approval from the U.S. Food and Drug Administration for the assay.
More »


Bio-Rad Extends Contract with Premier to Provide Quality Controls

Bio-Rad Laboratories announces that it has extended its contract with Premier, Inc., one of the largest group purchasing organizations based in the U.S.
More »


The Association for Talent Development Names Bio-Rad’s Quality Controls Customer Training Program a 2013 ‘Best Place to Learn’ Finalist

Bio-Rad Laboratories announced that its quality controls Customer Training program was named a ‘Best Place to Learn’ award Finalist by the Association for Talent Development (ATD), Dallas Chapter (formerly known as the American Society for Training and Development (ASTD).
More »


Bio-Rad Quality Controls Are Now Available in Dimension Vista Vials

Bio-Rad has announced a comprehensive line of multi-analyte quality controls now available in Siemens Dimension Vista® vials for use on Siemens Dimension Vista® Intelligent Lab Systems.
More »

Get Help
Sign Up for Bio-Rad Updates!
Enter your email address below to receive your choice of the latest news, promotions, and more.